Christopher Bunka - Oct 12, 2022 Form 4/A - Amendment Insider Report for Lexaria Bioscience Corp. (LEXX)

Role
Chief Executive Officer, Director
Signature
/Chris Bunka/
Stock symbol
LEXX
Transactions as of
Oct 12, 2022
Transactions value $
$78,397
Form type
4/A - Amendment
Date filed
10/18/2022, 06:20 PM
Date Of Original Report
Oct 13, 2022
Previous filing
Aug 29, 2022
Next filing
Oct 30, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LEXX common shares Purchase $43.5K +21.9K +10.14% $1.99 238K Oct 12, 2022 Private Holding Company F1
transaction LEXX common shares Purchase $34.9K +16.6K +6.98% $2.10 254K Oct 13, 2022 Private Holding Company F1
holding LEXX common shares 274K Oct 12, 2022 Direct
holding LEXX common shares 216K Oct 12, 2022 Private Holding Company
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This Form 4/A is being filed to correct the transaction code for the open market purchase of common shares made by Mr. Bunka as previously notated as a grant or award in the Form 4 originally filed on 10/13/2022.